BGI Genomics Co., Ltd. (SZSE:300676) signed a equity transfer agreement to acquire remaining 2.5% stake in Shenzhen BGI Medical Laboratory from Beijing BGI Research Centre Co., Ltd. for CNY 14.95 million on April 22, 2021. BGI Genomics Co., Ltd shall pay the Beijing Research Center in one lump sum by bank transfer in accordance with the currency and amount specified in the above clauses within 90 days from the effective date of this agreement. The funds for this transaction come from BGI Genomics Co., Ltd. own funds. Shenzhen BGI Medical Laboratory reported total assets of CNY 928.8138 million and Net assets of CNY 366.474 million for March 31, 2021. The board of directors of BGI Genomics Co., Ltd. approved the transaction in the 30th meeting of the second board of directors held on April 22, 2021.